Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Casein kinase 1δ-IN-9

Copy Product Info
😃Good
Catalog No. T64376Cas No. 854355-54-7

Casein kinase 1δ-IN-9 is a Quinone reductase 2 inhibitor with IC50 of 0.6μM.

Casein kinase 1δ-IN-9

Casein kinase 1δ-IN-9

Copy Product Info
😃Good
Purity: 99.93%
Catalog No. T64376Cas No. 854355-54-7
Casein kinase 1δ-IN-9 is a Quinone reductase 2 inhibitor with IC50 of 0.6μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$62-In Stock
5 mg$146-In Stock
10 mg$218-In Stock
25 mg$349-In Stock
50 mg$470-In Stock
100 mg$625-In Stock
200 mg$826-In Stock
1 mL x 10 mM (in DMSO)$133-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Casein kinase 1δ-IN-9 AI Summary
Casein kinase 1δ-IN-9 exhibits a high level of inhibition (99.0%) against Plasmodium falciparum Dd2 and 3D7 in whole red blood cells based on parasite LDH activity at 2 μM concentration. However, it shows no inhibition (0.0%) against Plasmodium falciparum 3D7 LDH activity in an LDH reporter assay at the same concentration and demonstrates no significant cytotoxicity in the human HepG2 cell line assay at 10 μM. The compound has an XC50 value of 664.32 nM in inhibiting Plasmodium falciparum 3D7 in whole erythrocytes. Additionally, it displays varying levels of bioactivity against multiple targets with EC50 values including: Salmonella typhi (>50000.0 nM), Chronic Active B-Cell Receptor Signaling (11220.2 nM), Vitamin D receptor (89125.1 nM), malarial parasite plastid (465.4 nM at 96-hour, 657.3 nM at 48-hour), TGF-b (12589.3 nM), Hepatitis C Virus (2511.9 nM), and others. It also shows 4.77% to 10.95% inhibition against transgenic Leishmania Mexicana promastigotes at 2 μM concentration. The compound's Inhibition Frequency Index (IFI) is 0.0%, indicating insignificant inhibition in non-kinase HTS assays..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Casein kinase 1δ-IN-9 is a Quinone reductase 2 inhibitor with IC50 of 0.6μM.
Chemical Properties
Molecular Weight269.73
FormulaC15H12ClN3
Cas No.854355-54-7
SmilesN(CC1=CC=CC=N1)C=2C3=C(N=CC2)C=C(Cl)C=C3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (203.91 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.7074 mL18.5371 mL37.0741 mL185.3706 mL
5 mM0.7415 mL3.7074 mL7.4148 mL37.0741 mL
10 mM0.3707 mL1.8537 mL3.7074 mL18.5371 mL
20 mM0.1854 mL0.9269 mL1.8537 mL9.2685 mL
50 mM0.0741 mL0.3707 mL0.7415 mL3.7074 mL
100 mM0.0371 mL0.1854 mL0.3707 mL1.8537 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Casein kinase 1δ-IN-9 | purchase Casein kinase 1δ-IN-9 | Casein kinase 1δ-IN-9 cost | order Casein kinase 1δ-IN-9 | Casein kinase 1δ-IN-9 chemical structure | Casein kinase 1δ-IN-9 formula | Casein kinase 1δ-IN-9 molecular weight